scholarly article | Q13442814 |
P356 | DOI | 10.1128/JVI.00687-11 |
P953 | full work available at URL | https://doi.org/10.1128/jvi.00687-11 |
https://europepmc.org/articles/PMC3194983 | ||
https://europepmc.org/articles/PMC3194983?pdf=render | ||
https://journals.asm.org/doi/pdf/10.1128/JVI.00687-11 | ||
https://jvi.asm.org/content/jvi/85/21/10934.full.pdf | ||
P932 | PMC publication ID | 3194983 |
P698 | PubMed publication ID | 21775463 |
P5875 | ResearchGate publication ID | 51508024 |
P2093 | author name string | Yan Yuan | |
Narayanan Sathish | |||
P2860 | cites work | Aids-related malignancies | Q22251046 |
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase | Q24290751 | ||
A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. | Q24293762 | ||
Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3... | Q24297037 | ||
Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation | Q24523761 | ||
Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 | ||
Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells | Q37634746 | ||
Virion proteins of Kaposi's sarcoma-associated herpesvirus | Q37744006 | ||
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays | Q38305362 | ||
Multiple regulatory domains control IRF-7 activity in response to virus infection | Q38310560 | ||
Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. | Q38341017 | ||
Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection | Q38610318 | ||
Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1. | Q39305101 | ||
Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. | Q39551686 | ||
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins | Q39585165 | ||
Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors | Q39593162 | ||
Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate | Q39606465 | ||
Modulation of Interferon Regulatory Factor 5 Activities by the Kaposi Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3 Contributes to Immune Evasion and Lytic Induction | Q39623528 | ||
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation | Q39910021 | ||
Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells | Q39996542 | ||
Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. | Q40128654 | ||
Kaposi's sarcoma: a review of the classical and epidemic forms | Q40203223 | ||
Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. | Q40311533 | ||
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
New viruses shake old paradigms | Q40364721 | ||
Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. | Q40468638 | ||
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection | Q40598301 | ||
Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. | Q40608568 | ||
Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties | Q40802330 | ||
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). | Q40961025 | ||
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences | Q40971183 | ||
Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors | Q40990994 | ||
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. | Q41365661 | ||
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response | Q41810499 | ||
A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction | Q41898857 | ||
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? | Q41984354 | ||
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. | Q42227558 | ||
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway | Q42834462 | ||
ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection | Q42931199 | ||
Interferon-β is required for interferon-α production in mouse fibroblasts | Q43412872 | ||
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 | ||
The murine double-stranded RNA-dependent protein kinase PKR and the murine 2',5'-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture | Q45721999 | ||
In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors | Q45854965 | ||
The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus | Q57662902 | ||
Kaposi's sarcoma: a reversible hyperplasia | Q69890531 | ||
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators | Q73787690 | ||
Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes | Q77137033 | ||
Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 | Q77758397 | ||
The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation | Q81304838 | ||
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300 | Q24533140 | ||
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 | ||
Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain | Q24551074 | ||
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF | Q24672442 | ||
Interferon-inducible antiviral effectors | Q27486790 | ||
Identification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory Protein | Q27489720 | ||
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma | Q27636336 | ||
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation | Q27642340 | ||
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 | Q28115232 | ||
PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene | Q28139719 | ||
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
Triggering the interferon antiviral response through an IKK-related pathway | Q28191761 | ||
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
Mechanisms of type-I- and type-II-interferon-mediated signalling | Q28247893 | ||
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors | Q28260114 | ||
Regulation of the type I IFN induction: a current view | Q28276339 | ||
Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6 | Q28292248 | ||
Toll-like receptors in innate immunity | Q28297257 | ||
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway | Q28592087 | ||
Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains | Q28608956 | ||
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling | Q28646137 | ||
Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? | Q29394711 | ||
MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling Pathways | Q29616209 | ||
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures | Q29618978 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions | Q30453077 | ||
Multiplex detection and quantitation of latent and lytic transcripts of human herpesvirus-8 using RNase Protection Assay | Q31121261 | ||
Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus | Q31156919 | ||
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis | Q35175590 | ||
Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis | Q35185925 | ||
Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors | Q35656534 | ||
Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. | Q35874857 | ||
A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε. | Q35885525 | ||
Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression | Q36099240 | ||
Type I interferons keep activated T cells alive | Q36367751 | ||
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells | Q36371359 | ||
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity | Q36446460 | ||
Conserved herpesvirus protein kinases | Q36491044 | ||
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview | Q36499704 | ||
Triggering the innate antiviral response through IRF-3 activation | Q36774934 | ||
Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin | Q37010247 | ||
Interferon regulatory factor family of transcription factors and regulation of oncogenesis | Q37055295 | ||
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5 | Q37136785 | ||
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis | Q37307209 | ||
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
Herpesvirus assembly: an update | Q37570980 | ||
Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling | Q37585525 | ||
Viral interferon regulatory factors | Q37588733 | ||
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus | Q33559699 | ||
Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. | Q33582093 | ||
Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. | Q33649357 | ||
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 | ||
Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter | Q33748042 | ||
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine | Q33761091 | ||
Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor | Q33784902 | ||
Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus | Q33815257 | ||
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 | Q33834993 | ||
Herpes simplex virus triggers and then disarms a host antiviral response | Q33835458 | ||
Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). | Q33841257 | ||
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor | Q33966269 | ||
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. | Q33967257 | ||
Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) | Q34069105 | ||
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. | Q34112056 | ||
Structure and function of IRF-7. | Q34114255 | ||
Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells. | Q34192731 | ||
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 | ||
A weak signal for strong responses: interferon-alpha/beta revisited | Q34238056 | ||
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR | Q34340317 | ||
Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation | Q34378427 | ||
Clinical presentation and natural history of AIDS--related Kaposi's sarcoma | Q34403706 | ||
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45 | Q34452746 | ||
Apoptosis and Cell Growth Inhibition as Antitumor Effector Functions of Interferons | Q34485664 | ||
Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function | Q34532718 | ||
Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback | Q34532725 | ||
Kaposi Sarcoma-associated Herpesvirus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing β-Interferon (TRIF) | Q34624150 | ||
Regulation of adaptive immunity by the innate immune system | Q34659642 | ||
Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry | Q34979001 | ||
Structure and function of latency-associated nuclear antigen | Q35124429 | ||
Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. | Q35150010 | ||
NF-kappaB inhibits gammaherpesvirus lytic replication | Q35155154 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | evasion of host immune response | Q1660157 |
P304 | page(s) | 10934-10944 | |
P577 | publication date | 2011-07-20 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview | |
Evasion and Subversion of Interferon-Mediated Antiviral Immunity by Kaposi's Sarcoma-Associated Herpesvirus: an Overview | |||
P478 | volume | 85 |
Q37992879 | Activation and regulation of interferon-β in immune responses. |
Q64969424 | Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease. |
Q38838059 | Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control. |
Q64093190 | Extracellular Vesicles From KSHV-Infected Cells Stimulate Antiviral Immune Response Through Mitochondrial DNA |
Q30603461 | Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein |
Q30406863 | Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses |
Q38408315 | Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways |
Q36169636 | Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses. |
Q90100096 | Homology-directed repair in mouse cells increased by CasRx-mediated knockdown or co-expressing Kaposi's sarcoma-associated herpesvirus ORF52 |
Q33677823 | Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. |
Q35208258 | Influence of ND10 components on epigenetic determinants of early KSHV latency establishment |
Q36052710 | Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein |
Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
Q37308737 | Intracellular interferons in fish: a unique means to combat viral infection |
Q89770486 | Kaposi Sarcoma-associated herpesvirus infection and endemic Burkitt's lymphoma |
Q40417350 | Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients |
Q99552055 | Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya |
Q41831354 | Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages |
Q36359794 | NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency. |
Q47551073 | RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism |
Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
Q27010116 | Recognition of human oncogenic viruses by host pattern-recognition receptors |
Q64375144 | Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene |
Q90483351 | Regulation of cGAS-Mediated Immune Responses and Immunotherapy |
Q37995595 | Tegument Proteins of Kaposi’s Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses |
Q47927359 | Tetrabromobisphenol A activates the hepatic interferon pathway in rats |
Q40237439 | The Heme Metabolite Carbon Monoxide Facilitates KSHV Infection by Inhibiting TLR4 Signaling in Endothelial Cells |
Q42266941 | The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression. |
Q96828977 | USP7 manipulation by viral proteins |
Q30384388 | Viruses and human cancers: a long road of discovery of molecular paradigms. |
Search more.